Education
About Us
Working with TipRanks
Follow Us
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
Earnings Data
Report Date
Mar 04, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.78Last Year’s EPS
-0.72Same Quarter Last Year
Strong Buy
Based on 11 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Rhythm Pharmaceuticals demonstrated strong revenue growth and regulatory progress, particularly for IMCIVREE in hypothalamic obesity. While international revenue faced challenges, the company's successful equity offering and promising data in BBS highlight a positive outlook. R&D costs are rising, but the overall sentiment remains optimistic.Company Guidance
Strong Revenue Growth
Rhythm Pharmaceuticals reported Q3 2025 revenue of $51.3 million, a 6% sequential increase from Q2 2025. The U.S. accounted for $38.2 million (74%) and international sales contributed $13.1 million (26%).
Successful Equity Offering
The company strengthened its balance sheet with a $189 million equity offering in July 2025.
Regulatory Progress for IMCIVREE
IMCIVREE's regulatory filings for acquired hypothalamic obesity were accepted by both the FDA and EMEA, with a PDUFA date set for December 20, 2025.
Promising Data in Bardet-Biedl Syndrome
A German study showed that 80% of patients with BBS experienced improvement in steatotic liver disease or stabilization at the lowest grade after 6 months of setmelanotide therapy.
RYTM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RYTM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $113.74 | $104.99 | -7.69% |
Aug 05, 2025 | $90.24 | $88.57 | -1.85% |
May 07, 2025 | $62.71 | $64.63 | +3.06% |
Feb 26, 2025 | $51.03 | $53.32 | +4.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Rhythm Pharmaceuticals Inc (RYTM) report earnings?
Rhythm Pharmaceuticals Inc (RYTM) is schdueled to report earning on Mar 04, 2026, TBA (Confirmed).
What is Rhythm Pharmaceuticals Inc (RYTM) earnings time?
Rhythm Pharmaceuticals Inc (RYTM) earnings time is at Mar 04, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RYTM EPS forecast?
RYTM EPS forecast for the fiscal quarter 2025 (Q4) is -0.78.